However, in si-ADAMTS9-AS1 + miR-301b-3p inhibitor group, the expression of those tumor makers was reversed (p < 0.05) (Figure 4D), indicating a reduced tumor proliferative activity. Here, ADAMTS9 is linked to neoplasm.